Trial intelligence / Profile preview

Intraosseous vs Intra-articular PRP vs HA in Knee OA

NCT03329235Phase 1Completed

Sponsor
Cangzhou Central Hospital
Start
Jan 2015
Primary completion
Jun 2015
Modality
Adipose-derived MSCs, Bone Marrow MSCs
01

Overview

Phase 1, randomised, open-label trial of platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by Cangzhou Central Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index at 18 months. Started Jan 2015; status: completed.

02

Drugs

platelet-rich plasma
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03329235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03329235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call